Skip to main content
Download PDF
  • Cas Clinique
  • Published:

Dopage aux androgènes dans le milieu sportif. Evaluation du risque médical. A propos du cas d'un patient qui pratique le bodybuilding

Androgen abuse in sportsmen. Evaluation of the medical risk in the case of a bodybuilder

Andrologie volume 14, pages 221–223 (2004)Cite this article

Resume

Ce dopage sportif est de plus en plus répandu, il concernerait 80% des adeptes du culturisme.

L'usage des anabolisants protéiques permet l'augmentation de la masse musculaire avec des doses équivalant jusqu'à 500 fois la dose thérapeutique.

Il existe un vrai risque de morbidité et de mortalité non connu des sportifs et mal connu des soignants.

Le but de cet article est de sensibiliser au dépistage des conduites dopantes aux androgènes et à la surveillance des effets secondaires de ces pratiques.

Abstract

Androgen abuse is increasingly frequent among sportsman and would appear to concern 80% of bodybuilders. The use of anabolic steroids increases the muscle mass at doses equivalent to about 500 times the therapeutic dose. There is a real risk of morbidity and mortality, not known to sportsmen and only poorly known to healthcare personnel. The purpose of this article is to increase awareness concerning screening for androgen abuse and surveillance of the adverse effects of these practices.

References

  1. APPLEBY M., FISHER M., MARTIN M.: Myocardial infarction, hyperkaliemia and ventricular tachycardia in a young male bodybuilder. Int. J. Cardiol., 1994, 44: 171.

    Article  PubMed  CAS  Google Scholar 

  2. BOYADJIEV N.P., GEORGIEVA K.N., MASSALDJIEVA R., GUEORGUIEV S.I.: Reversible hypogonadism and azoospermia: a result of anabolic androgenic steroid in a bodybuilder with personality disorder: case report. J. Sport Med. Phys. Fitness, 2000, 40: 271–274.

    CAS  Google Scholar 

  3. FINESCHI V., BAROLDI G., MONCIOTTI F., PAGLICCI REATTELLI L., TURILLAZI E.: Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch. Pathol. Lab. Med., 2001, 125: 253–255.

    PubMed  CAS  Google Scholar 

  4. FRANCKLE M.A., EICHERG R., ZACHARIA S.B.: Anabolic androgenic steroids and a strong and young athlete: case report. Arch. Phys. Med. Rehabil., 1988, 69: 632–633.

    Google Scholar 

  5. GAND F.: Le Généraliste. 1998, 403.

  6. GITTES S.: Carcinoma of the prostate. New Engl. J. Med., 1991, 324: 18.

    Google Scholar 

  7. JAILLARD A.S., HOMMEL M., MALLARET M.: Venous sinus thrombosis associated with androgens in young healthy man. Stroke, 1994, 25: 212–213.

    PubMed  CAS  Google Scholar 

  8. KNUTH V.A., MANIERA H., NIESHLAG E.: Reversible azoospermia induced by the anabolic 19 nortestosterone. Lancet, 1984, i: 417–420.

    Google Scholar 

  9. LARKIN L.: Carcinoma of the prostate — Letter to the editor. New Engl. J. Med., 1991, 324: 1893.

    Article  Google Scholar 

  10. LAURE P.: Dopage et société. Editions Ellipses, 1998: p. 331, tableau 68.

  11. LIOW R.Y., TAVARES S.: Bilateral rupture of the quadriceps tendon associated anabolic steroids. Br. J. Sports Med., 1995, 29: 77–79.

    Article  PubMed  CAS  Google Scholar 

  12. LOYD F.H., POWELL P., MURDOCH A.P.: Lesson of the week: Anabolic steroid abuse by bodybuilders and male subfertily. Br. Med. J., 1996, 313: 100–101.

    Google Scholar 

  13. Mc CARTHY A., TANG A.T., DALRYMPLE-MAY M.J., HAW M.P.: Ventricular thrombosis and systemic embolism in bodybuilding etiology and management. Ann. Thorac. Surg., 2000, 70: 658–660.

    Article  CAS  Google Scholar 

  14. POPE H.G., KATZ D.L.: Homicide and near homicide by anabolic steroid users. J. Clin. Psychiatr., 1990, 51: 260–261.

    Google Scholar 

  15. POPE H.G., KATZ D.L.: Psychiatric and medical effects of anabolic androgenic steroid use: A controlled study of 160 athletes. Arch. Gen. Psych., 1994, 51: 375–382.

    CAS  Google Scholar 

  16. REYES R.J., ZICCHI S., HAMED H., CHOUDARY M., FENTIMAN I.S.: Surgical correction of gynecomastia in bodybuilders. Br. J. Clin. Pract., 1995, 49: 172.

    Google Scholar 

  17. ROBERTS J.T., ESSENHIGH D.M.: Adenocarcinoma of prostate in 40 year old body builder. Lancet, 1986, 2: 742–743.

    Article  PubMed  CAS  Google Scholar 

  18. TUREK P.J., WILLIAM R.H., GILBAUGH J.H., LIPSHULTZ L.I.: The reversibility of anabolic steroid in azoospermia. J. Urol., 1995, 153: 1628–1630.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre d'Urologie et d'Andrologie, Clinique du Belvédère, 4 Avenue du Général Weygand, 06000, Nice, France

    Frédéric Colomb & Eric Jacob Benizri

  2. CDFA-CCAA, Nice

    Vincent Laroche & Olivier Laroche

Authors
  1. Frédéric Colomb
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincent Laroche
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Olivier Laroche
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric Jacob Benizri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frédéric Colomb.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Colomb, F., Laroche, V., Laroche, O. et al. Dopage aux androgènes dans le milieu sportif. Evaluation du risque médical. A propos du cas d'un patient qui pratique le bodybuilding. Androl. 14, 221–223 (2004). https://doi.org/10.1007/BF03034798

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03034798

Mots clés

Key words

Basic and Clinical Andrology

ISSN: 2051-4190